Why Your Azelaic Acid Might Not Be Working, and What Potassium Azeloyl Diglycinate Actually Is
Azelaic acid has one of the best safety records of any active in skincare and a reputation for being reliably underwhelming in practice. Most people who try it are chasing something specific, calmer redness, faded post-acne marks, fewer breakouts, and come away with a bottle that did very little. The active itself is not the problem. What is on the label often is.
This article covers the two most common reasons an azelaic acid product fails to deliver, why azelaic acid is one of the harder actives to formulate correctly, and how it differs from potassium azeloyl diglycinate, an ingredient that shows up in a growing number of "azelaic acid alternative" serums but is not azelaic acid at all. It ends with what this means for South Asian skin specifically, and how Qunat formulates with azelaic acid.
The Solubility Problem Nobody Puts on the Label
Azelaic acid is a nine-carbon dicarboxylic acid, and it is stubborn in a way that has nothing to do with the skin and everything to do with chemistry. It barely dissolves in water, at roughly a quarter of a gram per hundred millilitres at room temperature, and it is only moderately soluble in most cosmetic oils. Left in a standard water-based gel or serum base, a meaningful portion of it does not actually dissolve. It sits as suspended crystal, which means it can sit on the surface of the skin without ever getting into a form the follicle can use.
This is why azelaic acid is one of the few actives where the delivery system matters almost as much as the percentage on the label. Formulating it properly usually requires a microemulsion or a specific solubilising system built around it from the start, not a percentage of active stirred into a generic base that was designed for something else. A product can list twelve percent azelaic acid accurately and still deliver very little of it, simply because most of that twelve percent never went into solution.
Why Concentration Is the Real Divide
The clinical evidence for azelaic acid comes almost entirely from concentrations most retail products do not use. The two FDA-approved prescription formulations are a 15 percent gel and foam for rosacea and a 20 percent cream for acne. Most of the over-the-counter market sits well under that, frequently in the 5 to 10 percent range, and a five percent product is not a milder version of a twenty percent one. It is a different tier of active entirely, formulated to sit gently in a routine rather than to do the enzyme-inhibiting, antibacterial, and keratolytic work the clinical studies actually measured.
None of this makes low-concentration azelaic acid useless. It can still function as a mild, well-tolerated brightening and calming ingredient. The issue is expectation. A five percent gel and a properly solubilised twelve to twenty percent formula are not interchangeable, and a lot of the "azelaic acid did nothing for me" experience comes down to using the former while expecting the results reported for the latter.
What Potassium Azeloyl Diglycinate Actually Is
How It Works
Potassium azeloyl diglycinate, often shortened to PAD, is built by attaching two glycine amino acids to an azelaic acid backbone and neutralising it into a potassium salt. That change in structure is what makes it behave so differently from azelaic acid itself. The glycine groups make the molecule substantially more water-soluble, which solves the solubility problem outright, and they also change how the ingredient interacts with the skin. PAD is generally described as working through tyrosinase inhibition and mild anti-inflammatory activity, the same broad category of action as azelaic acid, but through a gentler, lower-irritation pathway.
What It Addresses
PAD is most often used for uneven tone, post-acne marks, and general brightening in formulations aimed at sensitive or reactive skin, typically at concentrations between two and ten percent. The tradeoff for that solubility and tolerability is potency. PAD does not carry the decades of rosacea and acne clinical trial data that azelaic acid has, and the published research on it is comparatively thin, mostly manufacturer-sponsored data and a handful of smaller trials rather than the FDA-reviewed studies behind Finacea and Azelex. It is a reasonable ingredient. It is not a one-to-one substitute, and it should not be marketed as though a five percent PAD serum will do what a twenty percent azelaic acid cream does.
How the Two Ingredients Actually Differ
The confusion between these two ingredients is understandable, since PAD is derived from azelaic acid and brands frequently market it under language like "azelaic acid derivative" or "gentle azelaic alternative" without explaining that it is a structurally distinct molecule with a different evidence base. Azelaic acid is the ingredient with the clinical track record, the higher effective concentrations, and the formulation difficulty. PAD is the ingredient built to sidestep that difficulty, at the cost of some of the potency that made azelaic acid worth using in the first place.
Neither is better in the abstract. Azelaic acid is the better choice when the goal is measurable improvement in inflammatory acne, rosacea-associated redness, or stubborn post-inflammatory hyperpigmentation, provided it is formulated at a real concentration and properly solubilised. PAD is the better choice for skin that reacts to azelaic acid's mild tingling or cannot tolerate it at all, with the understanding that results will likely be slower and less pronounced.
Side-by-Side Comparison
| Azelaic Acid | Potassium Azeloyl Diglycinate | |
|---|---|---|
| Structure | Nine-carbon dicarboxylic acid | Azelaic acid backbone bound to two glycine molecules, potassium salt |
| Water Solubility | Poor, requires microemulsion or dedicated delivery system | High, dissolves readily in water-based formulas |
| Effective Concentration | 15 to 20 percent in clinically studied, FDA-approved formulations | Typically 2 to 10 percent |
| Clinical Evidence | Extensive, including FDA-approved prescription formulations | Limited, mostly smaller or manufacturer-sponsored studies |
| Primary Concerns Addressed | Inflammatory acne, rosacea redness, stubborn hyperpigmentation | Mild uneven tone, general brightening, sensitive-skin maintenance |
| Irritation Potential | Moderate, mild tingling common on initial use | Low |
| Best For | Skin that tolerates active treatment and wants measurable correction | Reactive skin, or as a maintenance step alongside stronger actives |
Considerations for South Asian Skin
South Asian skin sits predominantly at Fitzpatrick IV to V, and post-inflammatory hyperpigmentation is typically a bigger long-term concern than the original blemish or patch of redness that caused it. This is exactly the profile azelaic acid was built for. Its tyrosinase-inhibiting action addresses the pigment left behind by acne or irritation, while its anti-inflammatory and antibacterial properties work on the underlying cause, which is part of why it shows up so often in formulations aimed at deeper skin tones.
The concentration issue matters more here, not less. A sub-therapeutic azelaic acid product will not meaningfully reduce inflammation, which means the cycle of breakouts and rebound pigmentation continues largely unaddressed. At the same time, azelaic acid at a properly formulated concentration is one of the gentler options available for actively treating hyperpigmentation, with a substantially lower risk of triggering new post-inflammatory marks compared to more aggressive acids or retinoids. PAD can be a reasonable entry point or maintenance step for skin that is not ready for a full-strength azelaic acid formula, but it should be treated as a bridge, not a replacement.
How Qunat Formulates With Azelaic Acid
AzelaiK 12% is built around micronized azelaic acid at a true 12 percent concentration, delivered through a microemulsion system rather than suspended in a standard gel base. Micronizing the particle size and pairing it with an emulsifying system built specifically to hold azelaic acid in solution is what allows the formula to actually reach the follicle instead of sitting on the surface as undissolved crystal.
The formula is built around betaine and green tea extract alongside the azelaic acid, supporting the skin through the mild tingling that can accompany initial use while the antibacterial and tyrosinase-inhibiting action goes to work on post-inflammatory erythema and hyperpigmentation. The goal is a concentration high enough to matter and a delivery system that makes sure it does.
AzelaiK 12% delivers a true 12 percent concentration of micronized azelaic acid through a dedicated microemulsion system, built to actually reach the follicle rather than sit undissolved in a standard gel base. Paired with betaine and green tea extract to support the skin through initial use, it targets post-inflammatory erythema and hyperpigmentation at a concentration formulated to matter.